All three options do look exciting but they cater to different segments of market participants and can't be bunched in one category. If someone wants to invest for long-term wealth creation, then ‘Bharat Bond ETF, Rosari Biotech, and Yes Bank IPO are preferred choice, filtered on the basis of wealth creation/protection of capital. … [Read more...] about Rossari Biotech IPO, Bharat Bond ETF & Yes Bank FPO: Where should investors put their money?
Hsbc bank middle east
For those who don’t remember the case, the context here is the RBI action to write down Yes Bank’s AT1 bonds as part of a rescue plan. A stock exchange clarification from Yes Bank’s RBI-appointed administrator, Prashant Kumar, in March said the AT1 bondholders will get nothing as per the condition of the reconstruction scheme. This, logically, came as a jolt to many investors, both retail and institutional. … [Read more...] about Banking Central: RBI ko gussa kyon aata hai?
The core voters of AAP and the Congress are the same: Muslims and the underprivileged living in unauthorised colonies and slums. Besides, there is a small section of the lower-middle class. It was this vote bank that handed power to AAP in 2015, when it earned 54 percent of the votes, while the BJP received 32 percent, and the Congress a little less than 10 percent. … [Read more...] about Politics | Has BJP taken the winds out of AAP’s and Congress’ sails?
"The new capacity expansion at Dahej (1,32,500 MTPA) with Rs 90 crore capex should strengthen its portfolio in the high-growth HPPC segment to serve its wide customer base. Customised product offering, fungible capacities and rapid finished product conversion rate remain the key differentiators for the company," said Emkay. It, too, favoured subscribing the issue. … [Read more...] about Analysts say subscribe to Rossari Biotech IPO despite high valuation, here is why
"There are a number of reasons why Rossari is a subscribe for short and long term investors alike. Fundamentally it is extremely strong with a topline, EBITDA and net profit CAGR of 32 percent, 63 percent and 67 percent respectively from FY17 to FY20," Nirali Shah, Senior Research Analyst at Samco Securities told Moneycontrol. … [Read more...] about Rossari Biotech IPO opens today, subscribed 34% so far on Day 1